These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 18421843)
1. [Diversity in mechanism of angiotensin II production and application of the suppressive agents]. Miyazaki T Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):178-9. PubMed ID: 18421843 [No Abstract] [Full Text] [Related]
2. [involvement of chymase in pathogenesis of cardiovascular diseases]. Urata H Nihon Rinsho; 2004 Mar; 62 Suppl 3():147-51. PubMed ID: 15171359 [No Abstract] [Full Text] [Related]
5. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition. Hanif K; Bid HK; Konwar R Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET? Ram CV; Deedwania PC Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307 [No Abstract] [Full Text] [Related]
8. [Debate concerning the optimal blockage of the renin-angiotensin system]. Choukroun G Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454 [No Abstract] [Full Text] [Related]
9. Moving beyond angiotensin II to also target aldosterone? Little WC; Kirkman PM J Am Coll Cardiol; 2009 Aug; 54(6):513-4. PubMed ID: 19643311 [No Abstract] [Full Text] [Related]
10. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias. Garg S; Narula J; Marelli C; Cesario D Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of angiotensin II interruption: evidence for antiinflammatory actions. Dagenais NJ; Jamali F Pharmacotherapy; 2005 Sep; 25(9):1213-29. PubMed ID: 16164395 [TBL] [Abstract][Full Text] [Related]
12. Cardiac angiotensin is upregulated in the hearts of unstable angina patients. Luft FC Circ Res; 2004 Jun; 94(12):1530-2. PubMed ID: 15217917 [No Abstract] [Full Text] [Related]
13. Angiotensin receptor blockers: novel role in high-risk patients. Javed U; Deedwania PC Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228 [TBL] [Abstract][Full Text] [Related]
14. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders. Krum H; Gilbert RE J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168 [TBL] [Abstract][Full Text] [Related]
15. Do studies with ACE N- and C-domain-selective inhibitors provide evidence for a non-ACE, non-chymase angiotensin II-forming pathway? Husain A; Li M; Graham RM Circ Res; 2003 Jul; 93(2):91-3. PubMed ID: 12881473 [No Abstract] [Full Text] [Related]
16. Introduction. The cardiovascular continuum in the 21st century: renin-angiotensin system blockade, the cardiovascular continuum in the 21st century. Probstfield JL; Weber MA Am J Cardiol; 2010 Jan; 105(1 Suppl):1A-2A. PubMed ID: 20102967 [No Abstract] [Full Text] [Related]
17. The physiological significance of the alternative pathways of angiotensin II production. Kramkowski K; Mogielnicki A; Buczko W J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979 [TBL] [Abstract][Full Text] [Related]
18. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction? McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527 [No Abstract] [Full Text] [Related]
19. Tissue angiotensin generation and regulation of vascular tone. Cockcroft JR; O'Kane KP; Webb DJ Pharmacol Ther; 1995 Feb; 65(2):193-213. PubMed ID: 7792315 [TBL] [Abstract][Full Text] [Related]